This inventor holds 1 USPTO granted patent. Top assignee: Syntex (u.s.a.) Inc.. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Joseph Gerard McGivern: Innovator in Calcium Channel Variants
Introduction
Joseph Gerard McGivern is a notable inventor based in Mountain View, CA (US). He has made significant contributions to the field of biochemistry, particularly in the area of calcium channel variants. His work has implications for various medical and therapeutic applications.
Latest Patents
McGivern holds a patent for T-type calcium channel variants, specifically TCCV-1 and TCCV-2. The patent details compositions and uses of these variants, including polynucleotides encoding TCCV-1 or TCCV-2, purified polypeptides, and specific antibodies. The invention also outlines methods for screening compounds that modulate the activity of TCCV-1 or TCCV-2, as well as diagnostic methods and kits.
Career Highlights
Throughout his career, McGivern has been associated with Syntex (U.S.A.) Inc., where he has contributed to various research initiatives. His expertise in calcium channels has positioned him as a key figure in the development of innovative solutions in the pharmaceutical industry.
Collaborations
One of his notable collaborators is Paul Shartzer Dietrich. Together, they have worked on advancing research related to calcium channels and their applications in medicine.
Conclusion
Joseph Gerard McGivern's contributions to the field of biochemistry, particularly through his patent on T-type calcium channel variants, highlight his role as an innovator. His work continues to influence research and development in therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile